GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare to Hold an Investor Day in New York City on November 21, 2024

CHICAGO--(BUSINESS WIRE)--

GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will host an investor day on Thursday, November 21, 2024, in New York, NY. GE HealthCare’s management team will present its growth strategies, technology portfolio, and vision for its businesses via a live webcast and will be accessible at . More information, including registration details, will be available as the date draws closer.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on , (formerly Twitter), and for the latest news, or visit our website for more information.

EN
06/05/2024

Underlying

GEHCVGE HEALTHCARE TECHNOLOGIES INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused...

CHICAGO--(BUSINESS WIRE)-- Today, GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and Medis Medical Imaging, a leading cardiac imaging software company, announced their collaboration aimed at helping advance precision care in the diagnosis and treatment of coronary artery disease (CAD). Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interve...

May 14, 2024 1 EN
 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare to Hold an Investor Day in New York City on November 21,...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will host an investor day on Thursday, November 21, 2024, in New York, NY. GE HealthCare’s management team will present its growth strategies, technology portfolio, and vision for its businesses via a live webcast and will be accessible at . More information, including registration details, will be available as the date draws closer. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated t...

May 6, 2024 1 EN
 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

Pushing the Boundaries of Neuroscience with GE HealthCare’s SIGNA MAGN...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR systems. Neuroscience, particularly in the study of psychiatric diseases and neurological disorders such as Alzheimer’s, has been constrained by technological and biological limitations, leaving many aspects of the brain structure and functionality largely unexplored. Today, 43% of the world’s population suffe...

May 5, 2024 1 EN
 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare Management to Present at Upcoming Investor Conferences

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC), is announcing that its Vice President and Chief Financial Officer, Jay Saccaro will be presenting at the following upcoming investor conferences. Bank of America Securities 2024 Healthcare Conference in Las Vegas – May 14, 2024 at 1:00 pm ET/10:00 am PT Jefferies Global Healthcare Conference in New York – June 5, 2024 at 10:00 am ET These events can be accessed at the GE HealthCare website: on the dates and times listed above. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharma...

May 2, 2024 1 EN
 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology S...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced Revolution RT,i a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients. The new Revolution RT is being unveiled at the in Glasgow, along with an updated and artificial intelligence (AI)-enhanced version of the Intelligent Radiation Therapy (iRT) platform, which interfaces with the Spectronic magnetic res...

May 1, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch